J. Boas

1.3k total citations
14 papers, 798 citations indexed

About

J. Boas is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, J. Boas has authored 14 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Epidemiology. Recurrent topics in J. Boas's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). J. Boas is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Epilepsy research and treatment (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). J. Boas collaborates with scholars based in Denmark, United Kingdom and Norway. J. Boas's co-authors include Per Soelberg Sørensen, Gudrun Boysen, Jan Larsen, Gorm Boje Jensen, Peter Schnohr, J Nyboe, Finn Somnier, Merete Appleyard, J Worm-Petersen and M. Dam and has published in prestigious journals such as Stroke, Movement Disorders and European Journal of Neurology.

In The Last Decade

J. Boas

13 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Boas Denmark 11 324 181 169 157 148 14 798
RM Poole United States 6 437 1.3× 114 0.6× 124 0.7× 99 0.6× 142 1.0× 8 1.2k
Reinhold Schmidt Austria 12 193 0.6× 75 0.4× 74 0.4× 76 0.5× 87 0.6× 18 703
Xiao‐He Hou China 15 164 0.5× 314 1.7× 182 1.1× 26 0.2× 133 0.9× 39 953
Nina J. Solenski United States 16 578 1.8× 62 0.3× 116 0.7× 41 0.3× 222 1.5× 39 1.2k
E. Bottacchi Italy 21 902 2.8× 160 0.9× 56 0.3× 69 0.4× 327 2.2× 49 1.5k
Sydney Louis United States 15 101 0.3× 385 2.1× 54 0.3× 310 2.0× 106 0.7× 31 904
Somchai Laowattana United States 6 80 0.2× 133 0.7× 215 1.3× 76 0.5× 161 1.1× 7 1.1k
Xiao Xu United States 16 122 0.4× 203 1.1× 33 0.2× 141 0.9× 125 0.8× 30 1.2k
C. Gómez–Escalonilla Spain 17 288 0.9× 100 0.6× 35 0.2× 42 0.3× 185 1.3× 38 778
J. Duarte Spain 17 397 1.2× 127 0.7× 37 0.2× 70 0.4× 105 0.7× 38 748

Countries citing papers authored by J. Boas

Since Specialization
Citations

This map shows the geographic impact of J. Boas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Boas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Boas more than expected).

Fields of papers citing papers by J. Boas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Boas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Boas. The network helps show where J. Boas may publish in the future.

Co-authorship network of co-authors of J. Boas

This figure shows the co-authorship network connecting the top 25 collaborators of J. Boas. A scholar is included among the top collaborators of J. Boas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Boas. J. Boas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Friis, M. L., O. Kristensen, J. Boas, et al.. (2009). Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurologica Scandinavica. 87(3). 224–227. 39 indexed citations
2.
Dupont, E., Anne‐Marie Nybo Andersen, J. Boas, et al.. (2009). Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patients. Acta Neurologica Scandinavica. 93(1). 14–20. 32 indexed citations
3.
Mogensen, Preben, Lillian Mørch Jørgensen, J. Boas, et al.. (2009). Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites. Acta Neurologica Scandinavica. 85(1). 14–17.
4.
Henriksen, Leif & J. Boas. (2009). Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa. Acta Neurologica Scandinavica. 71(4). 257–266. 10 indexed citations
5.
Reichmann, Heinz, et al.. (2004). Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations. Acta Neurologica Scandinavica. 111(1). 21–28. 48 indexed citations
6.
Sabers, Anne, M. Dam, J. Boas, et al.. (2003). Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurologica Scandinavica. 109(1). 9–13. 96 indexed citations
7.
Larsen, Jan, et al.. (1999). Does selegiline modify the progression of early Parkinson's disease? Results from a five‐year study. European Journal of Neurology. 6(5). 539–547. 75 indexed citations
8.
Wermuth, Lene, Per Soelberg Sørensen, Sally Timm, et al.. (1998). Depression in idiopathic Parkinson's disease treated with citalopram: A placebo-controlled trial. Nordic Journal of Psychiatry. 52(2). 163–169. 102 indexed citations
9.
10.
Dupont, E., J. Boas, B. Mikkelsen, Lene Wermuth, & J Worm-Petersen. (1996). The levodopa dose-sparing capacity of pergolide compared with that of bromocriptine. University of Southern Denmark Research Portal (University of Southern Denmark). 3. 9–12. 3 indexed citations
11.
Boas, J., M. Dam, M. L. Friis, et al.. (1996). Controlled trial of lamotrigine (Lamictal®) for treatment-resistant partial seizures. Acta Neurologica Scandinavica. 94(4). 247–252. 39 indexed citations
12.
Boas, J., J Worm-Petersen, E. Dupont, B. Mikkelsen, & Lene Wermuth. (1996). The levodopa dose‐sparing capacity of pergolide compared with that of bromocriptine in an open‐label, crossover study. European Journal of Neurology. 3(1). 44–49. 20 indexed citations
13.
Boysen, Gudrun, Per Soelberg Sørensen, Marianne Juhler, et al.. (1988). Danish very-low-dose aspirin after carotid endarterectomy trial.. Stroke. 19(10). 1211–1215. 85 indexed citations
14.
Boysen, Gudrun, J Nyboe, Merete Appleyard, et al.. (1988). Stroke incidence and risk factors for stroke in Copenhagen, Denmark.. Stroke. 19(11). 1345–1353. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by RM Poole Breakdown of academic impact, for papers by Reinhold Schmidt Breakdown of academic impact, for papers by Xiao‐He Hou Breakdown of academic impact, for papers by Nina J. Solenski Breakdown of academic impact, for papers by E. Bottacchi Breakdown of academic impact, for papers by Sydney Louis Breakdown of academic impact, for papers by Somchai Laowattana Breakdown of academic impact, for papers by Xiao Xu Breakdown of academic impact, for papers by C. Gómez–Escalonilla Breakdown of academic impact, for papers by J. Duarte
Rankless by CCL
2026